Ranked 4 of 20
Ion Peptides
Large catalog, fast dispatch, and hundreds of published certificates with endotoxin panels on most products.
Overall score
89.9
Strong. Board median 81.7.
Score breakdown
-
Purity
40% weight88.9
7 of 8 samples passed
-
Trust
25% weight96
6 of 7 checks earned in full
-
Delivery
20% weight91
2 business day median
-
Value
15% weight81
0.89x the market median per mg
Transparency checks
Each check is worth a fixed number of points. Together they make up the trust score of 96.
- Certificates readable before checkout 20 / 20
- Lot on certificate matches the vial 20 / 20
- Testing lab named 12 / 12
- Certificate verifies at the lab 13 / 13
- Mass spec identity confirmation 10 / 10
- Trading history (3 years) 6 / 10
- No public enforcement actions 15 / 15
Facts
- Headquarters
- Not disclosed
- Ships from
- United States
- Trading since
- 2023
- Payments
- Cards, Crypto
- Delivery
- 2 business day median, same-day dispatch before 1 PM PT
- Carriers
- USPS Priority, UPS. Free over $150
- Testing labs
- Janoshik Analytical, Vanguard Laboratory
What stands out
- Hundreds of lab-confirmed certificates
- Endotoxin testing on most of the catalog
- Same-day dispatch before 1 PM Pacific
Where it falls short
- Company address not published
- Catalog size makes batch rotation frequent
Product by product
Rank is this vendor’s position, by overall score, among the vendors with independent results for that compound. Purity and pass counts are for the compound alone. Price is the listed vial normalised to dollars per milligram.
| Product | Avg purity | Passed | Price | Rank |
|---|---|---|---|---|
| Ipamorelin Latest Dec 22, 2025 | 99.67% | 1 / 1 | $7.00/mg $35 / 5 mg , as Ipamo Buy | 3 of 11 |
| Semaglutide Latest Aug 8, 2026 | 99.66% | 1 / 1 | $7.80/mg $39 / 5 mg , as ION-1S Buy | 3 of 18 |
| Tirzepatide Latest Sep 19, 2026 | 99.70% | 1 / 1 | $4.90/mg $49 / 10 mg , as ION-2T Buy | 3 of 12 |
| BPC-157 Latest Jul 1, 2026 | 99.60% | 1 / 1 | n/a | 4 of 20 |
| GHK-Cu Latest Apr 6, 2026 | 99.81% | 1 / 1 | n/a | 4 of 15 |
| NAD+ Latest Feb 19, 2026 | 99.40% | 0 / 1 | $0.09/mg $44 / 500 mg Buy | 4 of 8 |
| Retatrutide Latest Oct 12, 2026 | 99.74% | 1 / 1 | $5.85/mg $59 / 10 mg , as ION-3R Buy | 4 of 14 |
| TB-500 Latest May 22, 2026 | 99.63% | 1 / 1 | n/a | 4 of 13 |
| Cagrilintide Listed, not yet tested | n/a | 0 | $11.8/mg $59 / 5 mg , as Cag Buy | unranked |
| PT-141 Listed, not yet tested | n/a | 0 | $3.70/mg $37 / 10 mg Buy | unranked |
| Tesamorelin Listed, not yet tested | n/a | 0 | $7.00/mg $70 / 10 mg , as Tesa Buy | unranked |
- Ipamorelin 3 of 11
1 of 1 passed, $7.00/mg , as Ipamo
Buy Ipamo - Semaglutide 3 of 18
1 of 1 passed, $7.80/mg , as ION-1S
Buy ION-1S - Tirzepatide 3 of 12
1 of 1 passed, $4.90/mg , as ION-2T
Buy ION-2T - BPC-157 4 of 20
1 of 1 passed, n/a
- GHK-Cu 4 of 15
1 of 1 passed, n/a
- NAD+ 4 of 8
0 of 1 passed, $0.09/mg
Buy NAD+ - Retatrutide 4 of 14
1 of 1 passed, $5.85/mg , as ION-3R
Buy ION-3R - TB-500 4 of 13
1 of 1 passed, n/a
- Cagrilintide unranked
0 of 0 passed, $11.8/mg , as Cag
Buy Cag - PT-141 unranked
0 of 0 passed, $3.70/mg
Buy PT-141 - Tesamorelin unranked
0 of 0 passed, $7.00/mg , as Tesa
Buy Tesa
Test history
Every independent result we hold for Ion Peptides, newest first. Fill is the measured quantity as a share of the label claim.
- Retatrutide Janoshik Analytical Pass
- Tirzepatide Vanguard Laboratory Pass
- Semaglutide Janoshik Analytical Pass
- BPC-157 Vanguard Laboratory Pass
- TB-500 Janoshik Analytical Pass
- GHK-Cu Janoshik Analytical Pass
- NAD+ Vanguard Laboratory Purity below 99.5%
- Ipamorelin Janoshik Analytical Pass